Next report date
Report period
Q1 2024
EPS estimate
—
Revenue estimate
—
−3.10 MUSD
557.71 KUSD
385.53 M
Om Provectus Biopharmaceuticals, Inc.
Sektor
Bransch
VD
Edward V. Pershing
Webbplats
Huvudkvarter
Knoxville
Employees (FY)
4
Grundat
2002
FIGI
BBG000PGR5K3
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
